A Peek Into The Market Before The Trading Starts
Pre-open movers US stock futures are higher this morning, as investors are awaiting retail sales data. Futures for the Dow Jones Industrial Average surged 45 points to 13,290.00 and S&P 500 index futures rose 6.40 points to 1,427.90. Nasdaq 100 futures gained 17 points to 2,727.00.
A Peek Into Global Markets European markets were higher today. The STOXX Europe 600 Index rose 0.63%, London's FTSE 100 Index gained 0.56%, French CAC 40 Index surged 1.34% and German DAX 30 index rose 0.79%.
Asian markets ended mostly higher, with Japan's Nikkei Stock Average rising 0.51%, China's Shanghai Composite falling 0.30% and Australia's S&P/ASX 200 dropping 0.10%. Hong Kong's Hang Seng index rose 0.06% and India's Sensex gained 0.21%.
Broker Recommendation Analysts at Jefferies upgraded Sprint Nextel (NYSE: S) from “underperform” to “hold.” The target price for Sprint has been raised from $3 to $7.
Sprint shares surged 7.85% to $6.18 in pre-market trading.
- ReneSola (NYSE: SOL) today announced that it has shipped 10 MW of its high-quality solar modules to saferay GmbH, a leading large-scale PV power plant installer in Germany. To read the full news, click here.
- Merck (NYSE: MRK) and AiCuris today announced that they have entered into an exclusive worldwide licensing agreement for AiCuris' novel portfolio of investigational medicines targeting Human Cytomegalovirus (HCMV), including letermovir (AIC246), an oral, late-stage antiviral candidate being investigated for the treatment and prevention of HCMV infection in transplant recipients. To read the full news, click here.
- Williams Interactive LLC, a wholly owned subsidiary of WMS Industries (NYSE: WMS), today announced the signing of multi-year licensing agreements with both Betsson AB and Unibet Group. To read the full news, click here.
- CAE (NYSE: CAE) today announced that it has won a series of military contracts valued at approximately C$200 million, the majority of which involves long-term, recurring training services. To read the full news, click here.
© 2014 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.